195 related articles for article (PubMed ID: 25689812)
1. Cost-effectiveness study of pediatric atopic dermatitis in Asia: atopiclair vs. regular emollient (AD-ATOP).
Tang MB; Leong KF; Ou LS; Munasir Z; Parekh PR; Azmi S; Low WH; Goh A
J Drugs Dermatol; 2015 Feb; 14(2):169-75. PubMed ID: 25689812
[TBL] [Abstract][Full Text] [Related]
2. An over-the-counter moisturizer is as clinically effective as, and more cost-effective than, prescription barrier creams in the treatment of children with mild-to-moderate atopic dermatitis: a randomized, controlled trial.
Miller DW; Koch SB; Yentzer BA; Clark AR; O'Neill JR; Fountain J; Weber TM; Fleischer AB
J Drugs Dermatol; 2011 May; 10(5):531-7. PubMed ID: 21533301
[TBL] [Abstract][Full Text] [Related]
3. The regular use of an emollient improves symptoms of atopic dermatitis in children: a randomized controlled study.
Tiplica GS; Boralevi F; Konno P; Malinauskiene L; Kaszuba A; Laurens C; Saint-Aroman M; Delarue A
J Eur Acad Dermatol Venereol; 2018 Jul; 32(7):1180-1187. PubMed ID: 29419920
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of a barrier-strengthening moisturizing cream as maintenance therapy vs. no treatment after an initial steroid course in patients with atopic dermatitis in Sweden--with model applications for Denmark, Norway and Finland.
Hjalte F; Asseburg C; Tennvall GR
J Eur Acad Dermatol Venereol; 2010 Apr; 24(4):474-80. PubMed ID: 19793150
[TBL] [Abstract][Full Text] [Related]
5. A cost-utility analysis of pimecrolimus vs. topical corticosteroids and emollients for the treatment of mild and moderate atopic eczema.
Pitt M; Garside R; Stein K
Br J Dermatol; 2006 Jun; 154(6):1137-46. PubMed ID: 16704646
[TBL] [Abstract][Full Text] [Related]
6. Treatment of pruritus in mild-to-moderate atopic dermatitis with a topical non-steroidal agent.
Veraldi S; De Micheli P; Schianchi R; Lunardon L
J Drugs Dermatol; 2009 Jun; 8(6):537-9. PubMed ID: 19537379
[TBL] [Abstract][Full Text] [Related]
7. Atopiclair.
Patrizi A; Raone B; Neri I
Expert Opin Pharmacother; 2009 May; 10(7):1223-30. PubMed ID: 19405795
[TBL] [Abstract][Full Text] [Related]
8. A multicenter, randomized, vehicle-controlled clinical study to examine the efficacy and safety of MAS063DP (Atopiclair) in the management of mild to moderate atopic dermatitis in adults.
Abramovits W; Boguniewicz M;
J Drugs Dermatol; 2006 Mar; 5(3):236-44. PubMed ID: 16573256
[TBL] [Abstract][Full Text] [Related]
9. MAS063DP is effective monotherapy for mild to moderate atopic dermatitis in infants and children: a multicenter, randomized, vehicle-controlled study.
Boguniewicz M; Zeichner JA; Eichenfield LF; Hebert AA; Jarratt M; Lucky AW; Paller AS
J Pediatr; 2008 Jun; 152(6):854-9. PubMed ID: 18492531
[TBL] [Abstract][Full Text] [Related]
10. A randomized, open-label study to evaluate an intermittent dosing regimen of fluticasone propionate 0.05% cream in combination with regular emollient skin care in reducing the risk of relapse in pediatric patients with stabilized atopic dermatitis.
Liu L; Ong G
J Dermatolog Treat; 2018 Aug; 29(5):501-509. PubMed ID: 29164960
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of tacrolimus ointment vs. standard treatment in patients with moderate and severe atopic dermatitis: a health-economic model simulation based on a patient survey and clinical trial data.
Hjelmgren J; Svensson A; Jörgensen ET; Lindemalm-Lundstam B; Ragnarson Tennvall G
Br J Dermatol; 2007 May; 156(5):913-21. PubMed ID: 17263826
[TBL] [Abstract][Full Text] [Related]
12. Emollient Acceptability in Childhood Atopic Dermatitis: Not All Emollients are Equal.
Hon KL; Kung JSC; Tsang KYC; Yu JWS; Lee VW; Leung TF
Curr Pediatr Rev; 2018; 14(2):117-122. PubMed ID: 28578641
[TBL] [Abstract][Full Text] [Related]
13. A double-blind, randomized, vehicle-controlled clinical study to evaluate the efficacy and safety of MAS063DP (ATOPICLAIR) in the management of atopic dermatitis in paediatric patients.
Patrizi A; Capitanio B; Neri I; Giacomini F; Sinagra JL; Raone B; Berardesca E
Pediatr Allergy Immunol; 2008 Nov; 19(7):619-25. PubMed ID: 18298424
[TBL] [Abstract][Full Text] [Related]
14. A randomised, double-blind, vehicle-controlled study to evaluate the efficacy and safety of MAS063D (Atopiclair) in the treatment of mild to moderate atopic dermatitis.
Belloni G; Pinelli S; Veraldi S
Eur J Dermatol; 2005; 15(1):31-6. PubMed ID: 15701590
[TBL] [Abstract][Full Text] [Related]
15. Patient-reported outcomes from a multicenter, randomized, vehicle-controlled clinical study of MAS063DP (Atopiclair) in the management of mild-to-moderate atopic dermatitis in adults.
Abramovits W; Hebert AA; Boguniewicz M; Kempers SE; Tschen E; Jarratt MT; Lucky AW; Cornelison RL; Swinyer LJ; Jones TM
J Dermatolog Treat; 2008; 19(6):327-32. PubMed ID: 18728923
[TBL] [Abstract][Full Text] [Related]
16. Cost and effectiveness of prescribing emollient therapy for atopic eczema in UK primary care in children and adults: a large retrospective analysis of the Clinical Practice Research Datalink.
Moncrieff G; Lied-Lied A; Nelson G; Holy CE; Weinstein R; Wei D; Rowe S
BMC Dermatol; 2018 Oct; 18(1):9. PubMed ID: 30373584
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of Maintenance Treatment with a Barrier-strengthening Moisturizing Cream in Patients with Atopic Dermatitis in Finland, Norway and Sweden.
Norrlid H; Hjalte F; Lundqvist A; Svensson Å; Tennvall GR
Acta Derm Venereol; 2016 Feb; 96(2):173-6. PubMed ID: 26304099
[TBL] [Abstract][Full Text] [Related]
18. Long-term emollient therapy improves xerosis in children with atopic dermatitis.
Boralevi F; Saint Aroman M; Delarue A; Raudsepp H; Kaszuba A; Bylaite M; Tiplica GS
J Eur Acad Dermatol Venereol; 2014 Nov; 28(11):1456-62. PubMed ID: 24267728
[TBL] [Abstract][Full Text] [Related]
19. Treatment of atopic dermatitis with KAM-3008, a barrier-based, non-steroidal topical cream.
Bomstein Y; Rozenblat S
J Dermatolog Treat; 2015 Oct; 26(5):426-30. PubMed ID: 25893370
[TBL] [Abstract][Full Text] [Related]
20. Reduction of relapses of atopic dermatitis with methylprednisolone aceponate cream twice weekly in addition to maintenance treatment with emollient: a multicentre, randomized, double-blind, controlled study.
Peserico A; Städtler G; Sebastian M; Fernandez RS; Vick K; Bieber T
Br J Dermatol; 2008 Apr; 158(4):801-7. PubMed ID: 18284403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
